Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AMLC. Marosi, Oskar A. Haas, Barbara Schneider et al.|Cancer Genetics and Cytogenetics|1992Cited by 74
Tegwondo: Development of a novel near-continuous dose-dense temozolomide regimen for the treatment of recurrent brain tumorsHerwig Strik, Mathias Bähr, Jan Hendrik Buhk et al.|Journal of Clinical Oncology|2008Cited by 7